Searchable Patents Journal

Search details
          Search details help

   Results per page

Currently viewing: Intellectual Property Office - Patents Journal : SPCs
From 2017 April 19th - 6674 to 2017 April 19th - 6674
Refine: 

  • Help on this tab
    • Page
    • Previous
    • 1
    • Next
Publication
Date
SPC No.SPC
Category
Details
Rows may repeat to show multiple inventors or applicants depending on "Sort By"
19 April 2017
(Journal 6674)
SPC/GB12/008Extensions LodgedApplicant: Laboratoire Theramex
6 Avenue Albert II, 98000 Monaco (MC)

Product: Nomegestrol acetate + free or esterified estradiol

Product Type: Medicinal
Authorised: UK EU/1/11/690/001 27 July 2011
UK EU/1/11/690/002 27 July 2011

Authorised Extension: C(2012)2827 20 April 2012

Patent No: EP1334725
Title: Estroprogestative Contraceptive Composition

SPC No: SPC/GB12/008
Date Lodged: 21 March 2017
19 April 2017
(Journal 6674)
SPC/GB12/051RejectedApplicant: The Kennedy Institute for Rheumatology Research
16 St John's Lane, LONDON, EC1M 4BS

Product: Adalimumab

Product Type: Medicinal
Authorised: CH (CH) 56221 16 April 2003
UK EU/1/03/256/001 8 September 2003
UK EU/1/03/256/002 8 September 2003
UK EU/1/03/256/003 8 September 2003
UK EU/1/03/256/004 8 September 2003
UK EU/1/03/256/005 8 September 2003
UK EU/1/03/256/006 8 September 2003

Authorised Extension:

Patent No: EP1941904
Title: TNF antagonists for use in adjunctive therapy to methotrexate in the treatment of autoimmune diseases.

SPC No: SPC/GB12/051
Date Lodged: 15 November 2012
19 April 2017
(Journal 6674)
SPC/GB13/004GrantedApplicant: Takeda Pharmaceutical Company Limited
1-1 Doshomachi 4-chome, Chuo-ku,, Osaka 541-0045, Japan

Product: Ceftaroline fosamil or a pharmaceutically acceptable salt thereof

Product Type: Medicinal
Authorised: UK EU/1/12/785/001 23 August 2012

Authorised Extension:

Patent No: EP1043327
Title: Phosphonocephem derivatives, process for the preparation of the same , and use thereof

SPC No: SPC/GB13/004
Date Granted: 27 March 2017
Maximum Period Expires On: 16 December 2023
19 April 2017
(Journal 6674)
SPC/GB13/035GrantedApplicant: Astellas Pharma Inc.
No.3-11, Nihonbashi-Honcho, 2-chome, Chuo-ku, Tokyo 103-8411, Japan

Product: Mirabegron or a salt thereof

Product Type: Medicinal
Authorised: UK EU/1/12/809/001-014 7 January 2013

Authorised Extension:

Patent No: EP1559427
Title: Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient.

SPC No: SPC/GB13/035
Date Granted: 27 March 2017
Maximum Period Expires On: 6 January 2028
19 April 2017
(Journal 6674)
SPC/GB13/078GrantedApplicant: Allergan, Inc.
2525 Dupont Drive, Irvine, California 92612, United States of America

Product: Botulinum toxin type A

Product Type: Medicinal
Authorised: FI 263103-5/2012 16 January 2013
UK PL 00426/0118 - 0061 4 September 2013
UK PL 00426/0074 - 0139 4 September 2013
UK PL 00426/0119 - 0047 4 September 2013

Authorised Extension:

Patent No: EP2145629
Title: Use of neurotoxin therapy for treatment of urological and related disorders

SPC No: SPC/GB13/078
Date Granted: 27 March 2017
Maximum Period Expires On: 14 July 2023
19 April 2017
(Journal 6674)
SPC/GB15/053GrantedApplicant: AstraZeneca UK Limited
2 Kingdom Street, London, W2 6BD

Product: Cangrelor or a pharmaceutically acceptable salt thereof

Product Type: Medicinal
Authorised: UK EU/1/15/994/001 23 March 2015

Authorised Extension:

Patent No: EP1007094
Title: Pharmaceutical compositions comprising a nucleotide analogue suitable for freeze drying.

SPC No: SPC/GB15/053
Date Granted: 27 March 2017
Maximum Period Expires On: 10 December 2022
19 April 2017
(Journal 6674)
SPC/GB17/024LodgedApplicant: ICOS CORPORATION
Lilly Corporate Center, Indianapolis, IN 46285, USA

Product: Idelalisib or a pharmaceutically acceptable salt thereof

Product Type: Medicinal
Authorised: UK EU/1/14/938/001-002 19 September 2014

Authorised Extension:

Patent No: EP1761540
Title: Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta

SPC No: SPC/GB17/024
Date Lodged: 20 March 2017
  • Page 1 of 1 (7 hits)
  • Page
  • Previous
  • 1
  • Next

Tell us about a problem